Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Margin

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 0.531.01-1.915.603.92

What is the latest Core EBITDA Margin ratio of GENPHARMASEC ?

The latest Core EBITDA Margin ratio of GENPHARMASEC is 0.53 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20240.53
Mar20231.01
Mar2022-1.91
Mar20215.60
Mar20203.92

How is Core EBITDA Margin of GENPHARMASEC Trending?

Years Core EBITDA Margin % Change
Mar2024 0.53
-47.52
Mar2023 1.01
Positive
Mar2022 -1.91
Negative
Mar2021 5.6
42.86
Mar2020 3.92 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Margin ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹113.0 Cr -10.1% -31.8% -49.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,956.1 Cr -7.9% -20.9% 55.2% Stock Analytics
KIRI INDUSTRIES ₹2,997.6 Cr -7.9% -5.2% 42.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,222.1 Cr -3.5% -17.5% 6.5% Stock Analytics
BODAL CHEMICALS ₹727.8 Cr -11.6% -10.9% -26.7% Stock Analytics
BHAGERIA INDUSTRIES ₹714.9 Cr -8.8% -8% 1.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-10.1%

-31.8%

-49.4%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses